跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,796 条关于
“generalised anxiety disorder”
全部
42,796
临床试验
38,492
药物
323
机构
19
资讯
3,962
10个月前
Zydus Lifesciences Secures First Drug Approval in China for Venlafaxine ER Capsules
5天前
Definium Advances DT120 Toward Regulatory Submission After Positive Phase III Results
上个月
Entropy Neurodynamics Secures Ethics Approval for World-First 72-Patient Basket Trial of IV Psilocin Across Eight Neuropsychiatric Indications
11个月前
First Health Canada-Approved Phase 2 Trial Investigates Psilocybin Microdosing for Generalized Anxiety Disorder
去年
Neuphoria Therapeutics Completes Phase 3 Enrollment for BNC-210 Social Anxiety Disorder Treatment
去年
Vistagen Initiates Phase 2 Repeat Dose Study of Fasedienol for Social Anxiety Disorder
11个月前
Neuphoria Therapeutics Advances BNC-210 Phase 3 Trial for Social Anxiety Disorder
2年前
MindMed's MM120 Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder
去年
MindMed Initiates Phase III Trial of MM120 (LSD) for Generalized Anxiety Disorder
去年
MindMed's MM120 Shows Promise in Phase 2b Trial for Generalized Anxiety Disorder
第 1 页,共 397 页
上一页
下一页